MYHEP ALL TABLET
Generic : Sofosbuvir (400mg) + Velpatasvir (100mg)
Treatment : Chronic Hepatitis C Virus (HCV) Infection
Pack size : 30 (Tablet)
Manufacturer : Mylan Pharmaceuticals Pvt Ltd – A Viatris Company
Made In : INDIA
PRODUCT INTRODUCTION
Myhep All Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.
Myhep All Tablet should be taken in the prescribed dose and duration. It can be taken with or without food, but take it at the same time daily. It is advised not to consume more than the recommended dose. It is important to inform your doctor if you have any health conditions such as liver or kidney disease. It is harmful to consume alcohol along with this medicine, so it is advised to limit or avoid alcohol. The course of the medicine should be completed for better results.
BENEFITS OF MYHEP ALL TABLET
In Treatment of Chronic hepatitis C virus (HCV) infection
HOW TO USE MYHEP ALL TABLET
HOW MYHEP ALL TABLET WORKS
SAFETY ADVICE
Alcohol
Pregnancy
Breast feeding
Driving
Myhep All Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
Kidney
Limited information is available on the use of Myhep All Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Liver
However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine.
SIDE EFFECTS
Common side effects of Myhep All
- Headache
- Tiredness
ADDITIONAL INFORMATION
Pack size – 30
pack form – tablet
MORE INFORMATION
Information Leaflet
Always read the patient information leaflet before commencing treatment.
Important: We advise you to always read the patient information leaflet inside the medication box, as the generic medication may not always entirely match the patient information leaflet listed. Please contact us if you have any questions.
